Royal Bank of Canada’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
Royal Bank of Canada's BVS Position: Q1 2026 in Review
Royal Bank of Canada increased its Bioventus (BVS) stake by 9.1% in Q1 2026, buying an estimated $990 and bringing the position to 1,413 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #6054.
Royal Bank of Canada first reported a position in BVS in Q1 2021 and has held it in 19 quarters since. The position peaked at $147K in Q4 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.
- Royal Bank of Canada held 1,413 shares of Bioventus worth $13K as of Q1 2026.
- Royal Bank of Canada bought 118 Bioventus shares in Q1 2026, an estimated $990.
- Bioventus made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6054 holding.
- Royal Bank of Canada first reported a position in Bioventus in Q1 2021 and has held it in 19 quarters since.
- Royal Bank of Canada's Bioventus position peaked at $147K in Q4 2021.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.